Mankind Pharma Ltd

About the company

## **How to check the Mankind Pharma Limited** **IPO** **allotment status?** When the allotment process is completed, you can check the status of your application on the Upstox app. Share allotment is generally done around five to six days after an IPO closes. Here’s a step-by-step guide on how to check the Mankind Pharma Ltd IPO allotment status: 1. Login to your Upstox account, using your six-digit PIN 1. After logging in, click on ‘Discover’ 1. On the ‘Discover’ page, you will find the ‘Invest in IPO’ section 1. Under the Invest in IPO section, you will find the ‘View all’ option 1. Once you click on ‘View all’, you will be directed to the ‘IPO’ tab 1. In the ‘IPO’ tab, click on ‘My applications’  1. In ‘My applications’, under the History section, your Mankind Pharma IPO allotment status will be mentioned ## **About Mankind Pharma Limited IPO** Incorporated in 1991, Mankind Pharma develops, manufactures, and markets a wide range of pharmaceutical and consumer healthcare products. Its products are used to treat various acute and chronic diseases. Over the years, the company has established “Mankind” as a well-recognized brand in India. In FY22, it was the fourth-largest pharmaceutical company in domestic sales and second largest in terms of sales volume. Meanwhile, its consumer healthcare business, which started in 2007, has established several brands like Manforce, Prega News, Unwanted-72. As on 31 March 2022, the company has 23 manufacturing facilities across India with a total installed capacity of 40.7 billion units. Its facilities have obtained various approvals from regulatory bodies, including USFDA, WHO and CDSCO. Along with manufacturing, the company has a pan-India distribution network with a field force of over 11,000 medical representatives. Mankind Pharma is coming out with its initial public offer (IPO). The IPO will be a complete offer for sales where existing shareholders and promoters sell over four crore shares. Meanwhile, the company shares will be listed on NSE and BSE. Here are key details about the Mankind Pharma IPO: Company Name| **Mankind Pharma Limited**|  | Company Type| **Private** ---|---|---|---|--- Founders Name|**R. C. Juneja**Mankind Pharma Limited IPO Price band|**₹1,026 – ₹1,080**   **Financial snapshot** **Particulars**| **FY 20**| **FY 21**| **FY 22**| **9M FY23** ---|---|---|---|--- **Revenue**|₹ 5865 crore|₹ 6214 crore|₹ 7781 crore|₹ 6696 crore **Net Profit**|₹ 1056 crore|₹ 1293 crore|₹ 1452 crore|₹ 1015 crore ## **Here’s a quick look at Mankind Pharma Limited IPO’s strengths, weakness, opportunities and risks (SWOT analysis)** ### **Strengths and opportunities** 1. The company has a diversified portfolio of products in the pharmaceutical formulations and consumer healthcare segment. It has a proven track record of building and scaling brands across different categories.   1. Between FY20 to FY22, the company's domestic sales increased from ₹6,064 to ₹8,219 crore, a CAGR growth of over 16%. 1. It has established and grown consumer healthcare franchises with brand recall. In FY22, over 80% of doctors in India prescribed company’s formulations.  1. The company has in-house R&D capabilities, which help develop niche pharmaceutical formulations to achieve better quality products. ### **Risks and threats** 1. The company’s business has extensive government regulations, and non-compliance with regulatory requirements will adversely affect the business and operations. 1. Some of the products the company offers come under price control mechanisms imposed by the government in India and in other countries. This may limit the revenue earned through certain of its products.   1. Operates in a highly competitive industry. Hence, intense competition or pricing pressure may adversely impact the market share. ## **Mankind Pharma Limited IPO details** ### **** **Mankind Pharma Limited IPO date** The company has filed its Draft Red Herring Prospectus with the market regulator SEBI. The offer document filed by the company with the SEBI mentions that the Mankind Pharma IPO’s opening date – in other words, the Mankind Pharma IPO launch date – will be 25th April 2023. The Mankind Pharma IPO closing date is 27th April 2023. After this, investors will be updated about the allotment status on 3rd May 2023. Investors, who have been allotted shares, can expect them to be credited to their demat account on 8 May 2023. The Mankind Pharma IPO listing date is 9 May 2023. The listing date is the date on which the shares of a company get listed on the bourses – NSE and BSE. ### **** **Mankind Pharma Limited** **IPO Price Band** The entire IPO is a book-built issue. The Mankind Pharma IPO price band has been set between ₹1,026 and ₹1,080 per share. Interested investors can choose a price within this band to apply for the IPO. The Mankind Pharma IPO listing price will be determined on 9th May 2023. The listing price is the price at which a company’s shares debut on the stock exchanges. **** **Mankind Pharma Limited IPO Lot size** The Mankind Pharma IPO details have been declared. The Mankind Pharma IPO lot size is set at 13 shares and an investor can apply for a minimum of 1 lot. Meanwhile, the Mankind Pharma IPO issue size is approx ₹4,326 crore. ## **How to apply for the Mankind Pharma Limited** **IPO?** If you are interested in this investment opportunity but unsure how to apply for the Mankind Pharma IPO, here are the steps that you need to follow. When the public issue opens for subscription, one can follow this step-by-step guide on how to apply for the Mankind Pharma Ltd IPO on Upstox: 1. Log in to your Upstox account, using your six-digit PIN 1. After logging in, click on ‘Discover’ 1. On the ‘Discover’ tab, you will find the ‘Invest in IPO’ section 1. Under the Invest in IPO section, look for the ‘Mankind Pharma IPO’ tab and click on it 1. Now fill in all the required information, like ‘bid price’ and ‘lot size’ 1. Confirm and click on ‘Apply’ 1. Accept the mandate on your UPI app ## **Open a demat account with Upstox to apply for the Mankind Pharma Limited** **IPO** To apply for the Mankind Pharma Ltd IPO, you need to mandatorily have a demat account. A demat account helps you hold the shares you buy in a dematerialised format. If you don’t have a demat account yet, you can open one with Upstox by visiting our website or by downloading the app. Here is a step-by-step guide on how to open a demat account with Upstox: 1. Click [ **here**](https://upstox.com/open-demat-account/\OpenOpen?landing_page=learning-center/demat-account/demat-account-opening-procedure) to visit the demat account opening page on the Upstox website.  1. Enter your phone number and other essential details  1. Upload the scanned copies of your PAN, Aadhaar card, a cancelled cheque and your bank statement as needed 1. Complete the e-verification using the OTP sent to your registered mobile number This is all it takes to open a demat account with Upstox. Easy and quick, right? [ ](https://upstox.com/open-demat-account/\Open\Open) ## **Upstox – trading app to apply for the Mankind Pharma Limited IPO** Applying for IPOs with Upstox is extremely easy. The user-friendly interface and top-notch security make Upstox one of the leading trading apps in India. You can apply for the Mankind Pharma IPO on Upstox, provided you have a demat account. As mentioned in the previous section, you can simply follow the steps to open a demat account with Upstox. The biggest advantage is that when you apply for an IPO using your Upstox account, the brokerage charges are zero. In fact, due to its robust features and minimal charges, Upstox is among the most preferred trading apps. Lakhs of Indians trust Upstox as it is a reliable trading platform that makes IPO applications easy.

Financial performance (₹ Cr)

IPO Roadmap / Timeline

1. IPO Opens

   Completed
   25 Apr 2023

   Bidding starts for all investor categories

2. IPO Closes

   Completed
   27 Apr 2023

   Last day to place your bid

3. Basis of Allotment

   Completed
   27 Apr 2023

   Share allotment finalised

4. Refund Initiation

   Completed
   04 May 2023

   Refunds credited for non-allottees

5. Credit to Demat

   Completed
   03 May 2023

   Allotted shares credited to demat account

6. Listing on Exchange

   Completed
   09 May 2023

   Shares list on NSE / BSE

Post-close dates are indicative as per SEBI T+3 listing framework and may change per registrar updates.